Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Oncology Research and Treatment is Scopus-indexed (Q3, CiteScore 2.4), WoS SCIE. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 2296-5262Verify ISSN ↗2296-5270Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 84 / 151 | 44th | Q3 |
| Oncology | 282 / 428 | 34th | Q3 |
| Cancer Research | 188 / 233 | 19th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present (also 1978–1997), best quartile Q3, CiteScore 2.4.
Oncology Research and Treatment is Q3 in Hematology (rank 84 of 151), Q3 in Oncology (rank 282 of 428) and Q4 in Cancer Research (rank 188 of 233), by CiteScore 2025.
Oncology Research and Treatment is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.4, which places it in quartile Q3 at the 44th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.482, quartile Q3, with an H-index of 59.
Oncology Research and Treatment is published by S. Karger AG. Its print ISSN is 2296-5262 and its online ISSN is 2296-5270.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Oncology Research and Treatment has an h-index of 63 and a 2-year mean of 1.09 citations per paper (OpenAlex). Its Scopus CiteScore is 2.4, quartile Q3. On 2-year citations it ranks #88 of 148 Scopus journals in Hematology.
Oncology Research and Treatment published 125 papers in 2025; its busiest recent year was 2017 with 196. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 57 research articles (2025–2026), authors are most often from Germany (61.7%), China (13.2%) and Switzerland (4.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (0.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.